Clinical Trials Browser

Phase 1 × INDUSTRY × Eflornithine × Clear all

NCT05879367 2025-06-25

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

Phase 1 Recruiting

Astrocytoma, Glioblastoma